top button
    Got Questions


Global IoT Summit 2018
Oct 31, 2018
The Leela Palace, Bangalore



    Connect to us
      Facebook Login
      Site Registration Why to Join

Facebook Login
Site Registration

Population Health Management Market - SWOT Analysis of Major Industry Segments

0 votes
3 views

As per the research report published by Transparency Market Research, the population health management solutions market will touch a market of US$69,000 Mn in valuation by 2025. This is a remarkable growth from the initial valuation reported in 2016 of US$18,500 Mn. Such an outstanding growth of the market is thus expected to be complemented by a similarly outstanding CAGR of 16.1% in the coming years of the forecast period.

Mergers and Acquisitions are Key Strategies for Leading Companies in Market

The competitive landscape of the global population health management solutions market is a fairly fragmented one with the presence of a number of key players. These leading companies are projected to opt for mergers, joint ventures, and takeovers with a view to cement their brand position on a global scale. For instance, CarePort was recently acquired by Allscripts with an objective to strengthen their product portfolio in the segment of acute care. In addition to this, other leading companies in the market are working towards developing more efficient solutions. This has encouraged more funding and investments to be poured into the research and development activities.

Planning To Lay Down Future Strategy? Request Brochure Of Population Health Management Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4174

Some of the key players in the global population health management solutions market include names such as Health Catalyst, ZeOmega, Cerner Corporation, UnitedHealth Group, and Business Machines Coroporation among others.

Several healthcare service providers have been working on multiple projects to enhance the quality of the general population. With the use of the population health management solutions systems, the clinical records and other health-related information of the patient can be accessed without much hassle. Moreover, with the advancements in the healthcare sector itself, is helping to drive the growth of the global health management solutions market. It is thus presenting a plethora of business opportunities for the leading players to offer a strong value proposition to the end-users.

Positive Government Support is Key for North America Market Growth

The global population health management solutions market has been predominantly led by North America. The growth of the North America market is attributed to the high awareness among the population in the region about the advantages of using health management solutions. Moreover, both the governmental and the non-governmental institutions are making targeted efforts for the management of chronic diseases. This has also helped in the development of the population health management solutions market in North America region.

To Obtain All-Inclusive Information On Forecast Analysis Of Population Health Management Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4174

On the other hand, the Asia Pacific market is expected to exhibit a strong growth rate over the course of the given forecast period. The primary reason behind the projected growth of the region is the presence of emerging economies such as India and China that are investing large sums for the overhaul of their domestic healthcare infrastructure. Other nations such as Japan and Australia are also emerging to be huge markets for these health management solutions platforms. The markets of the Middle East and Africa and Latin America are still in their infancy and are expected to grow at a steady pace in the coming years of the forecast period.

posted Feb 11 by Rohini Chaudhari

  Promote This Article
Facebook Share Button Twitter Share Button Google+ Share Button LinkedIn Share Button Multiple Social Share Button

Related Articles
0 votes

The market for U.S. population health management solutions is expected to see various strategies that are being adopted by market players to keep up with technological elevations. In a report that is being published by Transparency Market Research (TMR), most of the market players could constantly innovate in the market through means of the development of novel software and services. Apart from this, improvisation of existing offerings to keep up with the technological advancement in the market is also another factor that is driving the market. This could result in helping market players secure a totally reliable position in the industry. Some of the prominent market players that are involved with population health management solutions in the U.S. are Health Catalyst, Healthagen, and IBM.

In accordance with the statistics of TMR, the U.S. population health management solutions market could earn revenue of around US$ 45.7 bn by the year 2023 at a CAGR of 23.9% over the forecast timeframe that extends from the year 2015 to 2023. By the type of source, the services market is expected to achieve a higher growth rate between the year 2015 and 2023.

Planning To Lay Down Future Strategy? Request Brochure Of U.S. Population Health Management Solutions Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7412

Government Policies to Fuel Market Demand

The demand pertaining to the U.S. population health management solutions market is expected to gain momentum at the back of the robust enforcement of beneficial healthcare acts in the US. The demand for population health management solutions in the U.S. are expected to be encouraged by the soaring prevalence of chronic ailments in the US. Apart from this, the expanding size of the base of geriatric population in the country is likely to result in the augmented demand of the market. The regional market of North America is likely to be a popular choice for population health management solutions, taking into consideration the increase in total spending on healthcare in the last few years. This would offer an impetus to the said market.

There has been a growing demand for the implementation of effective and efficient population health management solutions owing to the alarming rise in the expenses related to healthcare. The U.S. government could, however, resort to the precise tracking of the health of the population. There could be a need for population health management solutions for the purpose of accomplishing the requirement to come up with healthcare enterprises that are patient-centric and organize an efficient population health management practices. As such, providers of healthcare are expected to incorporate population health management solutions at an increased rate.

To Obtain All-Inclusive Information On Forecast Analysis Of U.S. Population Health Management Solutions Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=7412

Expanding Geriatric Population to Impact Market Positively  

The market for population health management market in the U.S. has been classified on the basis of mode of operation, end user, and type of source. On the basis of source, population health management software and the population health management services are the two of the significant market categories of the population health management market in the U.S. Of the two the classifications, the category of population health management services is very likely to secure the foremost position in the said market. The fast advancement of this segment can be linked to the increasing requirement for high productivity and cost effectiveness that is being given by the population health management services. 

On the basis of end user, the market for U.S. population health management has been classified into diagnostic and imaging centers, medical device organizations, government insurance providers, research institutes, employers, pharmaceutical companies, private insurance providers, and healthcare providers. Of all of these categories, healthcare providers are poised for substantial growth during the period of forecast.

Increased expenditure on healthcare, private investments, and soaring consciousness regarding health in the domain of population health management solutions in the U.S. are attributed with the distinct progress of this market category. Furthermore, the increasing elderly population base across the country is also fuelling the improvisation and implementation of population health management solutions by the healthcare providers.

0 votes

As per the research report published by Transparency Market Research, the population health management solutions market will touch a market of US$69,000 Mn in valuation by 2025. This is a remarkable growth from the initial valuation reported in 2016 of US$18,500 Mn. Such an outstanding growth of the market is thus expected to be complemented by a similarly outstanding CAGR of 16.1% in the coming years of the forecast period.

Mergers and Acquisitions are Key Strategies for Leading Companies in Market

The competitive landscape of the global population health management solutions market is a fairly fragmented one with the presence of a number of key players. These leading companies are projected to opt for mergers, joint ventures, and takeovers with a view to cement their brand position on a global scale. For instance, CarePort was recently acquired by Allscripts with an objective to strengthen their product portfolio in the segment of acute care. In addition to this, other leading companies in the market are working towards developing more efficient solutions. This has encouraged more funding and investments to be poured into the research and development activities.

Planning To Lay Down Future Strategy? Request Brochure Of Population Health Management Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4174

Some of the key players in the global population health management solutions market include names such as Health Catalyst, ZeOmega, Cerner Corporation, UnitedHealth Group, and Business Machines Coroporation among others.

Several healthcare service providers have been working on multiple projects to enhance the quality of the general population. With the use of the population health management solutions systems, the clinical records and other health-related information of the patient can be accessed without much hassle. Moreover, with the advancements in the healthcare sector itself, is helping to drive the growth of the global health management solutions market. It is thus presenting a plethora of business opportunities for the leading players to offer a strong value proposition to the end-users.

Positive Government Support is Key for North America Market Growth

The global population health management solutions market has been predominantly led by North America. The growth of the North America market is attributed to the high awareness among the population in the region about the advantages of using health management solutions. Moreover, both the governmental and the non-governmental institutions are making targeted efforts for the management of chronic diseases. This has also helped in the development of the population health management solutions market in North America region.

To Obtain All-Inclusive Information On Forecast Analysis Of Population Health Management Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4174

On the other hand, the Asia Pacific market is expected to exhibit a strong growth rate over the course of the given forecast period. The primary reason behind the projected growth of the region is the presence of emerging economies such as India and China that are investing large sums for the overhaul of their domestic healthcare infrastructure. Other nations such as Japan and Australia are also emerging to be huge markets for these health management solutions platforms. The markets of the Middle East and Africa and Latin America are still in their infancy and are expected to grow at a steady pace in the coming years of the forecast period.

More Trending Reports by Transparency Market Research –

Back Table and Cart Covers Market –

https://www.prnewswire.com/news-releases/back-table-and-cart-covers-market-to-register-steady-3-2-cagr-during-2019-2027-transparency-market-research-300999428.html

Viral Vector & Plasmid DNA Manufacturing Market - 

https://www.prnewswire.com/news-releases/global-viral-vector--plasmid-dna-manufacturing-market-to-chart-23-3-cagr-from-2019-to-2027-transparency-market-research-301000176.html

0 votes

As per the research report published by Transparency Market Research, the population health management solutions market will touch a market of US$69,000 Mn in valuation by 2025. This is a remarkable growth from the initial valuation reported in 2016 of US$18,500 Mn. Such an outstanding growth of the market is thus expected to be complemented by a similarly outstanding CAGR of 16.1% in the coming years of the forecast period.

Mergers and Acquisitions are Key Strategies for Leading Companies in Market

The competitive landscape of the global population health management solutions market is a fairly fragmented one with the presence of a number of key players. These leading companies are projected to opt for mergers, joint ventures, and takeovers with a view to cement their brand position on a global scale. For instance, CarePort was recently acquired by Allscripts with an objective to strengthen their product portfolio in the segment of acute care. In addition to this, other leading companies in the market are working towards developing more efficient solutions. This has encouraged more funding and investments to be poured into the research and development activities.

Some of the key players in the global population health management solutions market include names such as Health Catalyst, ZeOmega, Cerner Corporation, UnitedHealth Group, and Business Machines Coroporation among others.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

Several healthcare service providers have been working on multiple projects to enhance the quality of the general population. With the use of the population health management solutions systems, the clinical records and other health-related information of the patient can be accessed without much hassle. Moreover, with the advancements in the healthcare sector itself, is helping to drive the growth of the global health management solutions market. It is thus presenting a plethora of business opportunities for the leading players to offer a strong value proposition to the end-users.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

Positive Government Support is Key for North America Market Growth

The global population health management solutions market has been predominantly led by North America. The growth of the North America market is attributed to the high awareness among the population in the region about the advantages of using health management solutions. Moreover, both the governmental and the non-governmental institutions are making targeted efforts for the management of chronic diseases. This has also helped in the development of the population health management solutions market in North America region.

0 votes

Pharmaceutical Excipients Market: Introduction

According to the report, the global pharmaceutical excipients market was valued at US$ 6.9 Bn in 2018 and is projected to expand at a high CAGR during the forecast period. Pharmaceutical excipients can be defined as the substances other than the active pharmaceutical ingredients employed in the formulation of pharmaceutical drugs. These are appropriately evaluated and incorporated intentionally in drug delivery systems.

The global pharmaceutical excipients market is driven by boost in growth of the global pharmaceuticals market. According to the IQVIA Institute for Human Data Science, the global pharmaceutical market accounted for over US$ 100 Bn in 2017. The market is anticipated to grow at a rate of over 5% to reach US$ 1.5 Trn by 2023. Europe dominated the global pharmaceutical excipients market in 2018 and the trend is anticipated to continue during the forecast period. Strong growth of the market in the region can be attributed to growing approval of biosimilars, contributing to rise in demand for excipients employed in the manufacturing of biosimilars.

Growing Demand for Plant Origin Excipients

Focus on development of excipients originated from plants has been gaining significance, owing to growing usage of these excipients as sweeteners, adhesives, binders, and suspenders. Pharmaceutical excipients of plant origin such as agar, starch, alginates, acacia gum, gelatin, and pectin are widely used in pharmaceuticals as gelling agents, coating materials, thickening agents, and binding agents. Specific applications of plant-based polymers in pharmaceutical formulations include their use in manufacturing of beads, microparticles, injectable and inhalable systems, nanoparticles, and implants. Various advantages of plant-based excipients include their biodegradable nature, non-toxicity, biocompatibility, low cost, and ease of availability. This is likely to drive the growth of the pharmaceutical excipients market.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12662

Growing Approvals of Oral Solid Dosage Drugs

Oral solid dosage is one of the most common routes of pharmaceutical drug administration. Excipients play a vital role in providing oral solid dosage drugs by offering better stability, drug release, bioavailability, taste, and texture. Oral solid dosage forms are easily transported, chemically stable, and cost-effective. The usage of tablets or capsules for drug products can provide various advantages such as increased chemical and physical stability, unique brand recognition by shape and color, convenience of handling, and controlled release options. According to the IMS Health, over nine of the top ten drugs based on the prescription volume were oral solid doses in 2019. Furthermore, according to the U.S. FDA, in 2018, over 31% of the 59 NMEs approved were oral solid dose products, of which 24 were tablets and seven were capsules. This growing approvals of oral solid dosage drugs will contribute positively to the growth of the pharmaceutical excipients market.

Organic Chemicals to Witness High Demand

Among products, the organic chemicals segment is likely to account for a major share of the global pharmaceutical excipients market during the forecast period. In the organic chemicals segment, the carbohydrates sub-segment dominated the market in 2018 and is likely to remain dominant during the forecast period. Growth of the sub-segment can be attributed to the high demand for natural excipients, such as the cellulose and sugars, which, in turn, boost the segment growth.

Oral Formulation is Most Preferred Mode of Administration

In terms of formulation, the global pharmaceutical excipients market has been divided into oral, topical, parenteral, and others. The oral segment held the largest market share in 2018 and the trend is anticipated to continue throughout the forecast period. Oral formulation is the most preferred mode of administration for a range of medications unless the patient is not in a position to accept oral solid medications. In addition, rise in approval of oral solid dosage formulations by the U.S. FDA contributes to the growth of the pharmaceutical excipients market.

Buy Now This Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=12662&ltype=S

Pharmaceutical Excipients Market: Prominent Regions

The global pharmaceutical excipients market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe dominated the global pharmaceutical excipients market in 2018. Growth of the pharmaceutical excipients market in the region can be attributed to strong presence of market players in the region, robust increase in the manufacture of biosimilars, and growing adoption of orphan drugs contributing to the strong demand for pharmaceutical excipients. The pharmaceutical excipients market in Asia Pacific is likely to expand at a high CAGR from 2019 to 2027. Growth of the market in the region can be attributed to increased outsourcing of drug manufacture to developing countries, such as India, owing to low costs of labor and raw materials in these countries.

Strategic Acquisitions by Key Players to Propel Global Market

The global pharmaceutical excipients market is consolidated, in terms of number of players. Key players operating in the global pharmaceutical excipients market are BASF SE, Colorcon Inc., Ashland, Inc., Croda International Plc, Roquette Frères, Evonik Industries AG, DuPont de Nemours, Inc., Associated British Foods plc, Archer Daniels Midland Company, and Lubrizol Corporation. These players have adopted various strategies such as acquisitions and partnerships to expand their portfolio of services as well as geographical presence.

More Trending Reports by Transparency Market Research –

Helicobacter Pylori (H. Pylori) Non-invasive Testing Market: prnewswire.com/news-releases/helicobacter-pylori-h-pylori-non-invasive-testing-market-to-be-worth-us-700-mn-by-2026-says-tmr-685104651.html

Brain Computer Interface Market: prnewswire.com/news-releases/brain-computer-interface-market-to-be-worth-us-12-billion-by-2024-demand-increases-with-growing-prevalence-of-brain-disorders—tmr-682767451.html

0 votes

Non-invasive diagnosis is a procedure of identifying a disease without or with minimal incision of the body. These methods involve different techniques such as identifying genetic structure, biomarkers, changes in molecular biology, along with imaging technologies. Cancer is a disease related to genetic alteration of the cells and therefore causing uncontrolled growth and forming tumor like structure.

Report overview @ https://www.transparencymarketresearch.com/noninvasive-cancer-diagnostics-market.html

Imaging is the preferred method of cancer detection but cannot have genetic access; on the other hand biopsies which have genetic access are complicated and difficult to perform repetitively during the course of cancer diagnosis and therapy. Therefore newer techniques developed in lines with non invasive diagnosis such as molecular diagnosis, serum based immunoassays and chemical tests to identify chemical components in the body especially from blood and urine. All these procedures are performed either with non-surgical or minimal surgical procedures; therefore these non-invasive cancer diagnostic techniques are becoming more and more popular among healthcare practitioners. 

According to WHO and World Cancer Report, by 2020, new cancer cases will be around 15 million annually, of which breast, ovarian and GI cancer are expected to be most commonly occurring types. Cancer is the disease condition which has highest prevalence rate all over the world and causes considerable amount of burden on economies. Therefore early and accurate detection of cancer along with monitoring its growth at later stages is very critical. Though invasive types of cancer diagnoses are accurate in early stages, the same procedures cannot be used for monitoring growth of cancer at different stages since surgeries are required for these types of diagnoses.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8197

Non-invasive cancer diagnostics market can be segmented by various categories such as by region, by techniques and according to different types of oncological conditions. Geographically Non invasive cancer diagnostic market is segmented in four regions mainly North America, Europe, Asia-Pacific and Rest of the World.

The non-invasive cancer diagnosis has growth potential all across the world; however developed countries such as USA, UK, Japan, Canada and some emerging economies such as India, China, Brazil and Russia are observed to experience highest growth in demand for non-invasive cancer diagnostic. 

Out of all these four geographies, the contribution from North America is highest followed by Europe, Asia-Pacific and Rest of the World. Higher awareness among healthcare fraternity, availability of advanced diagnostic technologies in North America and European countries may help sustain the growth of non-invasive cancer diagnostics in these regions. On the other hand increasing incidences and prevalence of cancer and rising awareness in Asia-Pacific countries have created demand for non-invasive cancer diagnostic market sizably.

Pre Book Non-Invasive Cancer Diagnostics Market Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=8197&ltype=S

On the basis of techniques for non invasive cancer diagnosis, market can be segmented in molecular biology, serum immunoassay and clinical component identification in blood and serum. As different types of cancer causes different molecular, biological and chemical changes in body therefore this market can be divided according to cancer types such as blood cancer, lung cancer, breast cancer, ovarian cancer, skin cancer and others. 

There are many companies operating in non invasive cancer diagnostic in market out of them Roche Diagnostics, Quidel, Immunicon Corporation, Compugen, DiagnoCure, Abbott Molecular, GE Healthcare, Precision Therapeutics, Affymetrix Inc, , Digene Corporation are the major contributor in this market. Introduction of various advanced technologies such as Cologuard by Exact Sciences will pave the way for the future of this market. In March 2014, the U.S. FDA approved the product for non-invasive testing of colorectal cancer which is one of the most frequently occurring types of cancer observed in recent years. 

More Trending Reports by Transparency Market Research –

Liquid Biopsy Market: prnewswire.com/news-releases/liquid-biopsy-market-to-cross-us9071-7-million-by-2026—says-tmr-300864391.html

HIV/AIDS Diagnostics Market: prnewswire.com/news-releases/hivaids-diagnostics-market-to-touch-us5-74-billion-by-2025—says-tmr-300827872.html

...